Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$62.50 - $109.58
Next Earnings Date
May 01 2025
Next Earnings Date
May 01 2025
Latest price
Market Cap | $2.02B |
EV | $1.91B |
Shares Outstanding | 22.84M |
Beta | 0.88 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $105.63 |
P/E 2025E | 40.03x |
P/Revenue 2025E | 8.44x |
Revenue | 12.50% |
EPS | 15.60% |
Operating Cash Flow | 7.90% |
Free Cash Flow | 7.10% |
Revenue | 8.80% |
EPS | 12.50% |
Operating Cash Flow | - |
Free Cash Flow | 24.80% |
Gross Margin 2025E | 69.66% |
Net Profit Margin 2025E | 21.57% |
ROE 2025E | 14.10% |
ROCE 2024 | 13.87% |
DPS 2025E | $0.65 |
Payout Ratio 2025E | 29.02% |
Div. Yield 2025E | 0.72% |
DPS Last 3Y CAGR | 13.30% |
Price
%
1M
3M
6M
1Y
3Y
5Y
LeMaitre Vascular, Inc.
LMAT
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
LeMaitre, George
Employees
658
Website
www.lemaitre.comIPO Date
2006-10-19
Headquarters
63 Second Avenue, Burlington, Massachusetts, 01803, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved